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Figures 8 and 10 in “The interactions between GPR30 and the major biomarkers in infiltrating ductal carcinoma of
the breast in an Asian population” (Taiwan J Obstet Gynecol 2007;46[2]:135–145) by Wen-Hung Kuo, Li-Yun Chang,
Daisy Li-Yu Liu, Hsiao-Lin Hwa, Jen-Jen Lin, Po-Huang Lee, Chiung-Nien Chen, Huang-Chun Lien, Ray-Hwang Yuan,
Chia-Tung Shun, King-Jen Chang, and Fon-Jou Hsieh appeared in black and white on pages 143 and 144, respec-
tively, instead of color. The figures are reproduced in color below.
Figure 8. Survival analysis of G-protein-coupled receptor 30 (GPR30) and/or its associated clinical parameters in infiltrating
ductal carcinoma. (A) The effects of estrogen receptor α (ERα), progesterone receptor (PR), human epidermal growth factor
receptor-2 (HER-2/neu) and GPR30 mRNA levels (higher or lower than the group mean) on patient survival curves. (B) The
co-expression of ER and GPR30 on patient survival curves. The results of pairwise comparisons are: GPR30 > −6, ER > −1.8
vs. GPR30 < −6, ER > −1.8 (p = 0.519); GPR30 > −6, ER < −1.8 vs. GPR30 < −6, ER < −1.8 (p = 0.905); and GPR30 > −6,
ER > −1.8 vs. GPR30 < −6, ER < −1.8 (p = 0.020). (C) The co-expression of PR and GPR30 on patient survival curves. The
results for pairwise comparisons are: GPR30 > −6, PR > −5.5 vs. GPR30 < −6, PR > −5.5 (p = 0.329); GPR30 > −6, PR < −5.5






































































































GPR30 < −6, ER > −1.8 (34)
GPR30 > −6, ER > −1.8 (38)
GPR30 > −6, ER < −1.8 (15)
GPR30 < −6, ER < −1.8 (31)
ER > −1.8, PR > −5.5 (49)
ER > −1.8, PR < −5.5 (23)
ER < −1.8, PR > −5.5 (8)
ER < −1.8, PR < −5.5 (38)
p = 0.3827
GPR30 < −6 (65)
GPR30 > −6 (53)
p = 0.0025
ER < −1.8 (47)
ER > −1.8 (73)
p = 0.0003
PR < −5.5 (61)
PR > −5.5 (57)
p = 0.8301
HER-2/neu < 1.5 (66)


























































































GPR30 < −6, ER+ (35)
GPR30 > −6, ER+ (47)
GPR30 > −6, ER− (5)
GPR30 < −6, ER− (26)
GPR30 < −6, PR+ (33)
GPR30 > −6, PR+ (35)
GPR30 > −6, PR− (14)
GPR30 < −6, PR− (27)
A B
Figure 10. Survival analyses for the co-expression status of (A) G-protein-coupled receptor 30 (GPR30) and estrogen 
receptor α (ERα); and (B) GPR30 and progesterone receptor (PR). The results for pairwise comparisons are: GPR30 > −6,
ER+ vs. GPR30 < −6, ER+ (p = 0.874); GPR30 > −6, ER− vs. GPR30 < −6, ER− (p = 0.730); GPR30 > −6, ER+ vs. GPR30 < −6,
ER− (p = 0.015); and GPR30 > −6, PR+ vs. GPR30 < −6, PR+ (p = 0.894); GPR30 > −6, PR− vs. GPR30 < −6, PR− (p = 0.775);
GPR30 > −6, PR+ vs. GPR30 < −6, PR− (p = 0.005), respectively.
